Eric A. Swanson Biography
Eric Swanson is an active participant in a variety of entrepreneurial, industrial, academic, and volunteer activities. He chairs the board of directors for Acacia Communications and is a member of the boards of directors for NinePoint Medical and Curata and is an affiliate of the MIT Deshpande Center for Entrepreneurship and MIT Translational Fellows Program.
He is a cofounder or founding board member of five startup companies: Advanced Ophthalmic Devices (an ophthalmic OCT company acquired by Zeiss Meditec in 1994), Lightlab Imaging (a cardiovascular OCT company), Sycamore Networks (Nasdaq IPO 1999), Acacia Communications (Nasdaq IPO 2016), and Curata (private). These companies have evolved over time and shipped well over $1B in products around the world. During 16 years in various technical and managerial roles at MIT Lincoln Laboratory he participated in the discovery and advancement of OCT and worked on optical networks (including one of the first wavelength division multiplexed all-optical networks) and space communication (including one of the first intersatellite laser communication systems).
He has co-authored 81 journal articles, 142 conference presentations, 40 US patents, and 7 book chapters. In 2017 he was elected a fellow of the Institute of Electrical and Electronics Engineers for contributions to OCT and leadership in optical networking. In 2002 he was elected a fellow of the Optical Society (OSA) for pioneering contributions to the fields of intersatellite laser communication systems, fiber optic communication networks, and biomedical optical imaging. He is a co-recipient of the 2017 Russ Prize, the 2012 António Champalimaud Vision Award, and the 2002 Rank Prize in Optoelectronics.
Mr. Swanson holds a BS summa cum laude in electrical engineering from the University of Massachusetts Amherst and an MS in electrical engineering from MIT.
Peter Knight Biography
Professor Sir Peter Knight is Principal of the Kavli Royal Society International Centre at Chicheley Hall, President of the Institute of Physics and Professor of Quantum Optics at Imperial College London.
He was until September 2010 Deputy Rector (Research) at Imperial College responsible for the College’s research strategy. He was knighted in the Queen’s Birthday Honours List in 2005 for his work in optical physics. Sir Peter is the immediate past chair of the Defence Scientific Advisory Council at the UK Ministry of Defence and continues to advise on the use of science within UK government bodies. He is a Council member of the Science and Technology Facilities Council.
His research centres on theoretical quantum optics, strong field physics and especially on quantum information science and is an ISI “Highly Cited Author. He has won a number of prizes and awards including the Thomas Young Medal and the Glazebrook Medal of the Institute of Physics, the Royal Medal of the Royal Society and the Ives Medal of the OSA.
He has been a Visiting Professor at the University of Louvain-la-Neuve, a Humboldt Research Award holder at the University of Konstanz and a Visiting Scholar at the University of Texas at Austin and at the University of Rochester, and was Chief Scientific Advisor at the National Physical Laboratory.
He is a Fellow of the Institute of Physics, the Optical Society of America and of the Royal Society.
Gabriel Aeppli Biography
Gabriel Aeppli is Professor of Physics at the ETH Zurich and the EPF Lausanne. He is also head of the Synchrotron Radiation and Nanotechnology Department at the Paul Scherrer Institute. His current research focuses on the implications of photon science for data technology and healthcare.
He received a doctorate in electrical engineering at the Massachusetts Institute of Technology (MIT), Cambridge, USA, and spent most of his career in the private sector (NEC, Bell Laboratories and IBM), where he worked on a variety of subjects such as liquid crystals and magnetic data storage. He then co-founded and became director of the London Centre for Nanotechnology, Quain Professor at University College London and also co-founded the Bio-Nano Consulting company.
He is a consultant for many private and public organizations worldwide (in China, Australia, Europe and the USA) which deal with financing, evaluating and managing technology. He is an elected member of the American Academy of Arts and Sciences, the US National Academy of Sciences and the Royal Society (London) and has received many other awards, including the Mott Prize of the Institute of Physics in London and the Oliver Buckley Prize of the American Physical Society.
Gabriel Aeppli has been a member of the Swiss Science and Innovation Council since 2016.
Lars Samuelson Biography
Lars Samuelson obtained his Ph.D. in Solid State Physics at Lund University in 1977 followed by a Post-doc at IBM Research Laboratories in San José, CA. In 1986 he became Professor at Chalmers in Göteborg and returned in 1988 to a Professorship in Lund, where he has since then been engaged as leader of Nanoscience research. He has published more than 600 papers in refereed journals (h-index≈77; m-index≈2.0). He is Member of the Royal Swedish Academy of Sciences, KVA (Physics) and of the Royal Swedish Academy of Engineering Sciences, IVA. In 2008 he was awarded as “Einstein Professor” by the Chinese Academy of Sciences, in 2011 the Ideon Prize for Innovation, and in 2013 the IUVSTA Prize for Science of the Triennium 2010–2013, and in 2014 he was awarded the “Fred Kavli Distinguished Lectureship in Nanoscience”.
Beside his role as academic researcher and teacher, he has engaged himself in creation of spinout companies and is the primary founder and Chief Scientific Officer (CSO) of the companies QuMat AB (i), QuNano AB (ii), GLO AB (iii), Sol Voltaics AB (iv), and Hexagem AB (v), engaged in fields like:
(i): Materials; ii): Electronics; iii): LEDs/displays; iv): Solar cells; v): Power/RF.)
Morten Sommer Biography
Morten Sommer is Professor at DTU. He received his PhD from Harvard University in Biophysics. Before starting his own lab he worked with professors George Church, Stephen Quake and Sine Larsen.
Morten Sommer now works on understanding and harnessing evolutionary processes and biological diversity. Genome and metagenome wide screens and perturbations are used in conjunction with synthetic biology tools to understand the evolution and phenotypic stability of biosynthetic processes, drug resistance and complex microbial communities.
In the past five years Morten Sommer has received more than 100 M DKK in research funding to his group, including an ERC starting grant and a Sapere Aude group leader grant.
He has started several companies including Biosyntia (2012), AntibioTx (2011) and Microlytic (2006), which was recently acquired by Anatrace.
Morten Sommer has published 25 peer revieved papers and is the co-inventor on 15 patents and patent applications licensed to public and private companies in the US and Europe.
He is currently directly supervising 8 PhD students and 9 post docs.